When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Sarcopenia

Última revisão das evidências: 21 Mar 2026
Última atualização do tópico: 27 Sep 2023

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • low hand grip strength
  • difficulty rising from chair
  • difficulty climbing stairs
  • slow gait
  • emaciation
  • difficulty performing activities of daily living
Detalhes completos

Outros fatores diagnósticos

  • presence of comorbidities affecting muscle mass and/or function
Detalhes completos

Fatores de risco

  • age ≥65 years
  • low or high body mass index (BMI)
  • sedentary lifestyle
  • low protein intake
  • falls
  • smoking
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • serum electrolytes
  • blood glucose
  • LFTs
  • renal function tests
  • thyroid function tests
  • CBC
  • serum vitamin D
  • dual-energy x-ray absorptiometry (DXA)
  • CT
  • MRI
Detalhes completos

Investigações a serem consideradas

  • bioimpedance analysis (BIA)
Detalhes completos

Algoritmo de tratamento

AGUDA

all patients

Colaboradores

Autores

Gustavo Duque, MD, PhD

Professor

Faculty of Medicine

McGill University

Quebec

Canada

Declarações

GD serves as a member of the Advisory Boards of Abbott Australia and TSI Pharmaceuticals. He also belongs to the speakers' bureau for Amgen and Abbott Australia. These companies produce therapeutic compounds that have demonstrated an effect on sarcopenia

Guy Hajj-Boutros, PhD(c)

PhD candidate

Division of Experimental Medicine

McGill University

Quebec

Canada

Declarações

GHB declares that he has no competing interests.

José A. Morais, MD

Professor

Faculty of Medicine

McGill University

Quebec

Canada

Declarações

JAM has served as a consultant for Structure Therapeutics, USA. He has received operating grants from the Canadian Institutes of Health Research. JAM has also performed contracted research for Amazentis, Switzerland.

Revisores

Stephanie Anne Studenski, MD, MPH

Professor Emeritus

Department of Medicine

University of Pittsburgh

Pittsburgh

PA

Declarações

SAS declares that she has no competing interests.

Miles Witham, PhD

Professor of Trials for Older People and consultant geriatrician

NIHR Newcastle Biomedical Research Centre

Newcastle University

Newcastle

UK

Declarações

MW declares that he has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

​Cruz-Jentoft AJ, Bahat G, Bauer J, et al; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31.Texto completo  Resumo

​Dent E, Morley JE, Cruz-Jentoft AJ, et al. International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging. 2018;22(10):1148-61. Resumo

​Bhasin S, Travison TG, Manini TM, et al. Sarcopenia definition: the position statements of the Sarcopenia Definition and Outcomes Consortium. J Am Geriatr Soc. 2020 Jul;68(7):1410-8. Resumo

Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020 Mar;21(3):300-7. Resumo

Izquierdo M, Merchant RA, Morley JE, et al. International exercise recommendations in older adults (ICFSR): expert consensus guidelines. J Nutr Health Aging. 2021;25(7):824-53.Texto completo  Resumo

​Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014 May;69(5):547-58.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Diagnósticos diferenciais

    • Parkinson disease
    • Amyotrophic lateral sclerosis
    • Myopathy
    Mais Diagnósticos diferenciais
  • Diretrizes

    • Sarcopenia: revised European consensus on definition and diagnosis
    • International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management
    Mais Diretrizes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal